Celadon Pharmaceuticals LSE-listed Celadon Pharmaceuticals announced that it had signed a new commercial sales contract set to be worth
The UK’s National Health Service (NHS) Research Ethics Committee this week approved the full-scale rollout of a new clinical trial
SUMMERWAY Capital’s (LON: SWC) £80m reverse takeover of one of the UK’s few licenced high-THC cannabis growers has seen it relaunch its shares on the London Stock Exchange (LSE) in order to fund its new acquisition.Â
We won’t spam you
© 2023 Prohibition Holdings Ltd. All Rights Reserved.
